Kai Zheng

Dr. Kai Zheng received his Ph.D. from Department of Pharmaceutical Chemistry at the University of Kansas. After graduation, he joined Pharm. Technical Development department in Genentech at Oceanside, California and focused on formulation development of biotherapeutics at early stage. In 2011, Dr. Zheng joined Late Stage Pharmaceutical Development department in Genentech at South San Francisco site, where he focuses on Phase III and commercial formulation development of biotherapeutics and related regulatory filings. Dr. Zheng was vice president 2015.

He has been a board member and volunteer of Chinese Bioscience Association (CBA) in the last three years. His duty in CBA includes managing CBA membership and helping organizing numerous workshops and annual conferences.